José Castro

Has grant

Assistant Professor

Faculty of Medicine, University of Lisbon
Country flagPortugal

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

José Castro is an Assistant Professor at Universidade de Lisboa Faculdade de Medicina in Portugal. His research primarily focuses on neuromuscular disorders, with recent publications addressing topics such as jitter measurement in neuromuscular junction diseases, neuropathic pain in hereditary transthyretin amyloidosis, and motor neuron dysfunction in amyotrophic lateral sclerosis. His work includes both clinical and neurophysiological studies, contributing valuable insights into the pathophysiology of these conditions.

Recent Grants

Grant: Close

Spinal circuitry in Motor Neuron Disease: Changes in Spinal and Corticospinal Mechanisms in Amyotrophic Lateral Sclerosis and its variants

Open Date: 2020-01-01

Close Date: 2024-01-01

Grant: Close

Projecto Estratégico - LA 5 - 2011-2012

Open Date: 2011-01-01

Close Date: 2013-02-17

Articles (15)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Introduction: In neuromuscular diseases, respiratory failure is a major complication. Pulmonary function tests are generally used to assess respiratory function but can be influenced by a number of factors. Nerve conduction studies of the phrenic nerve (PN) is a simple, noninvasive, and safe method to assess diaphragm compromise in neuromuscular diseases. Methods: A group of 132 (78 males) healthy subjects, aged between 23 and 90 years, was studied, with bilateral stimulation of the PN, with recording of diaphragm motor responses. Anthropometric variables (sex, age, height, and weight) were collected, and their influence on diaphragm motor response was assessed. Side-to-side differences were also analyzed. Results: PN compound muscle action potential (CMAP) had significantly higher amplitude and area on the left side. Men had longer latency, and higher amplitude and area when compared with women, on both sides. Age was a significant factor influencing CMAP latency, with an average increase of 0.25 ms per decade of life. In men, a latency longer than 9.5 ms and a CMAP amplitude lower than 0.62 mV should be considered abnormal, while in women, the values are 8.5 ms and 0.48 mV, respectively. Conclusions: PN conduction studies offer a simple and reliable technique readily applicable in clinical settings. Diaphragm CMAP parameters are significantly influenced by the anthropometric variables of sex and age. Notably, CMAP amplitude and area are greater for the left PN.

Year:

2025

Year:

2025

Background and Aims Domino liver transplantation (DLT) has been used to address the shortage of donor organs. However, recipients of liver grafts from patients with hereditary transthyretin amyloidosis (ATTRv) develop de novo transthyretin (TTR) amyloidosis. Our aim is to describe the clinical presentation of patients with acquired TTR amyloidosis and compare the rate of neuropathy progression (NP) with untreated ATTRv amyloidosis with neuropathy (ATTRv‐NP) patients. Methods Patients with acquired TTR amyloidosis after DLT followed at a reference centre were evaluated. Medical records were reviewed for clinical characterization and systematic assessment of neuropathy. NP was defined as an increase in neuropathy impairment score of the lower limbs (NIS‐LL) at 12 months and compared to a historical control group of untreated ATTRv amyloidosis patients. Results Twenty‐four patients with acquired ATTR amyloidosis were included. Time from DLT to neuropathy onset was 9 2.0 years and the majority of patients reported feet sensory changes as first symptom. Thirteen patients with ≥ 2 evaluations with 12‐months interval were analysed. Almost all patients developed a neuropathic phenotype with small nerve fibre involvement. Neuropathy progression was similar to untreated ATTRv‐NP patients. Interpretation Recipients from liver grafts of ATTRv patients develop de novo amyloidosis with clinical presentation and NP similar to untreated ATTRv amyloidosis patients. Study of these patients might help elucidate the pathways for ATTR fibril formation.

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Collaborators (4)

Isabel Conceição

Universidade de Aveiro

PORTUGAL
View details

Javier Rodriguez-Falces

Associate Professor

Public University of Navarre

SPAIN
View details

Mamede de Carvalho

-

PORTUGAL
View details

Michael Swash

Queen Mary University of London

UNITED KINGDOM
View details